Nomograms including UBC® Rapid Test to detect primary bladder cancer based on a multicenter data set.

To evaluate the clinical utility of the urinary bladder cancer antigen UBC® Rapid Test for the diagnosis of bladder cancer (BC) and to develop and validate nomograms to identify patients at high-risk of primary BC.